These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 7638777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [Abstract] [Full Text] [Related]

  • 6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 7. [Antiphospholipid syndrome and exogenic risk factors in thromboses].
    Tikhonova TL, Mach ES, Shirokova IE, Reshetniak TM.
    Ter Arkh; 2004 Jun; 76(11):71-4. PubMed ID: 15658543
    [Abstract] [Full Text] [Related]

  • 8. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Shirokova IE, Lisitskaia TL.
    Ter Arkh; 2006 Jan; 78(6):24-30. PubMed ID: 16881359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
    Tektonidou MG, Sotsiou F, Moutsopoulos HM.
    J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Arterial hypertension and the antiphospholipid syndrome].
    Nasonov EL, Karpov IuA, Alekberova ZS, Vil'chinskaia MIu, Fomicheva OA, Aleksandrova EN, Reshetniak TM, Kliukvina NG, Andreev AIa.
    Ter Arkh; 1996 Oct; 68(2):37-40. PubMed ID: 8771655
    [Abstract] [Full Text] [Related]

  • 20. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
    Sipek-Dolnicar A, Hojnik M, Rozman B, Vizjak A, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):707-10. PubMed ID: 11020961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.